CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 4,570 shares at an average $198.75 ($908,301)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 122 shares at $191.38 ($23,348)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 200,000 shares at an average $191.42 ($38,283,382)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 785 shares at $204.13 ($160,244)
- 4 Planned sale CEO AND PRESIDENT sold 5,623 shares at $204.13 ($1,147,838)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 1,745 shares at $204.13 ($356,212)
- 4 Planned sale Director sold 127 shares at $204.13 ($25,925)
- 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 707 shares at $204.13 ($144,322)
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 915 shares at $204.13 ($186,781)
- 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 8,398 shares at an average $196.08 ($1,646,696)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 3,070 shares at an average $200.23 ($614,710)
- 4 Planned sale CEO AND PRESIDENT sold 3,950 shares at an average $200.02 ($790,095)
Page 11 of 94 · 1,862 filings